|
 |
|
      |
|
|
» Apply for a Grant
- FAQs - Young Investigator - Independent Investigator - Distinguished Investigator - Staglin Award
» Project Summaries
» Prizes - Lieber Prize - Falcone Prize - Ruane Prize - Goldman-Rakic Prize - Freedman Award - Klerman Award » For Grantees - Young Investigator Fact Sheet - Independent Investigator Fact Sheet - Distinguished Investigator Fact Sheet - Staglin Award Fact Sheet 
|
 Young Investigator  2006 Young Investigator Award Recipients R. Alison Adcock, M.D., Ph.D. Duke University Correlated Activation in Midbrain and Hippocampus as a Predictor of Memory: fMRI in Schizophrenic and Control Subjects Evdokia Anagnostou, M.D. Mount Sinai School of Medicine Brain Glutamate Concentrations in Autistic Adolecents by Magnetic Resonance Spectroscopy Julie Audet, Ph.D. University of Toronto Effect of Lithium on Signal Transduction Dynamics in Somatic Stem Cells David A. Baker, Ph.D. Marquette University Cystine-Glutamate Exchange and the Phencyclidine Model of Schizophrenia Ranita Basu, M.D. Western Psychiatric Institute and Clinic University of Pittsburgh Psychosocial Stress, Cortisol & Insulin Resistance and Risk of Cardiovascular Disease in Schizophrenia Anita Bechtholt, Ph.D. University of Pennsylvania Examining the Mechanisms of Chronic Antidepressant Efficacy Cecile Beguin, Ph.D. Harvard Medical School Harvard University Synthesis and Evaluation of Salvinorin A Analogues as Kappa-opioid Receptor Ligands for the Treatment of Mood Disorders Saloua Benmansour, Ph.D. University of Texas Health Science Center at San Antonio Influence of Ovarian Hormones on the Interaction Between Antidepressants and Serotonin Transporter Gregor E. Berger, M.D. Orygen Research Centre University of Melbourne Genetic Modulators of Clinical & Neurobiological Outcomes in Early Psychosis: A Genotype to Phenotype Approach Zubin Bhagwagar, M.D. Yale School of Medicine A Proton MRS Study of GABA and 5-HT Interactions Elisabeth Binder, M.D., Ph.D. Emory University Chaperones of the Glucocorticoid Receptor, Depression and Early Life Stress Seth Blackshaw, Ph.D. Johns Hopkins School of Medicine The Role of Tanycytes in Hypothalamic Plasticity and Regeneration: Relevance to Molecular Mechanisms of Depression Hugh T. Blair, Ph.D. University of California, Los Angeles Modulation of Serotonergic Neural Activity by Fear and Anxiety Sondra Bland, Ph.D. University of Colorado, Boulder Mechanisms of Stressor Controllability Modulation of Stress-induced Changes in Neurogenesis and Basic Fibroblast Growth Factor Expression in the Rat Hippocampus William Bobo, M.D. Vanderbilt University Medical Center Vanderbilt University Effect of Addition of Modafinil (MOD) on the Tolerability and Efficacy for Cognition to Atypical Antipsychotic Drugs in Patients with Schizophrenia (SCH) or Schizoaffective Disorder (SCHAD) Maura Boldrini, M.D., Ph.D. University of Florence Tryptophan Hydroxylyases Protein in the Raphe Nucleus from a Matched Set of Subjects with Bipolar Disorder, Depression, Schizophrenia and Controls with and without Suicide Leslie Born, M.Sc., Ph.D. St. Joseph's Healthcare, Hamilton McMaster University Development of a Female-Specific Interview Tool to Improve Diagnosis of Depression & other Mental Illnesses in Women across the Reproductive Lifecycle David Cristopher Bragg, Ph.D. Massachusetts General Hospital Analysis of DISC1 and its Role in Neurite Outgrowth and Synapse Formation Allegra Broft, M.D. Columbia University Imaging of Dopamine Systems in Bulimia Nervosa Peter Bulow, M.D. Columbia University Treating Depression with Transcranial Direct Current Stimulation Edgar A. Buttner, M.D., Ph.D. McLean Hospital/Harvard University Pharmacogenomics of Caenorhabditis Elegans Used to Discover Novel Genetic Targets of Psychoactive Medications Adalberto Campo-Arias, M.D. Universidad Autonoma de Bucaramanga Searching for Schizophrenia Genes: A Study Using the Association between Schizophrenia and Nicotine Addiction Dara M. Cannon, Ph.D. National Institute of Mental Health (NIMH/NIH) Dopamine Receptor Imaging in Mood Disorders Eran Chemerinski, M.D. Mount Sinai School of Medicine Cognitive Enhancement in the Schizophrenia Spectrum with Dihydrexidine Sufen Chiu, M.D., Ph.D. University of California, Davis Pediatric Psychosis and Schizophrenia Kodavali Venkata Chowdari, Ph.D. University of Pittsburgh Mechanisms of Altered GAD67 and mRNA Expression in Schizophrenia Francesca Cicchetti, Ph.D. Centre de Recherche Université Laval Robert-Giffard Laval University The Role of Inflammation in Schizophrenia Anis Contractor, Ph.D. Northwestern University Dopaminergic Regulation of Excitatory Synapses in the CA3 Region of the Hippocampus Donald Channing Cooper, Ph.D. University of Texas Southwestern Medical Center at Dallas The Molecular and Physiological Signature of Psychosis in the Hippocampal Prefrontal Cortical Pathway Miles G. Cunningham, M.D., Ph.D. McLean Hospital/Harvard University A Developmental Model for Structural Defects in Schizophrenia Zafiris Daskalakis, M.D., Ph.D., FRCP Centre For Addiction and Mental Health University of Toronto Enhancing Working Memory Performance and Gamma Band Synchrony in Patients with Schizophrenia Using Repetitive Transcranial Magnetic Stimulation (TMS) Carmen de Groote, Ph.D. University of Strathclyde In Vivo Magnetic Resonance Imaging of Glutamate and GABA Transmission in Schizophrenia Vincenzo De Luca, M.D. Centre For Addiction and Mental Health University of Toronto Suicide in Major Psychosis: Parent of Origin Effect and Genomic Imprinting in Serotonin and Norepinephrine System Genes J. Bruno Debruille, M.D., Ph.D. Douglas Hospital Research Centre McGill University Neurocognitive Mechanisms Underlying the Maintenance of Delusions: A Longitudinal Study in 1st Psychotic Episode Patients Gabriel S Dichter, Ph.D. University of North Carolina-Chapel Hill The Neural Influence of Affective Dysregulation on Executive Function in Unipolar Major Depression Daniel P. Dickstein, M.D. Bradley Hospital/Brown University Reversal Learning in Pediatric Bipolar Disorder Anna Dobretsova, Ph.D. University of Arkansas for Medical Sciences Neuron-oligodendrocyte Interactions in a Developmental Model of Schizophrenia Alex Dranovsky, M.D., Ph.D. Columbia University Effects of Stress and Antidepressants on Cellular and Circuit Plasticity of Adult-Born Hippocampal Neurons Michael R. Drew, Ph.D. Columbia University The Role of Adult Hippocampal Neurogenesis in Fear Conditioning Candice Drouin, Ph.D. University of Pennsylvania Impact of Noradrenergic Afferents on the Firing Properties of Mesocortical and Mesolimbic Neurons in the Ventral Tegmental Area Cristiane S. Duarte, Ph.D. Columbia University Childhood Depression and Obesity: Correlates and Pathways Katherine N. DuHamel, Ph.D. Beth Israel Medical Center A Motivation Intervention Based Approach to Increasing Adherence among Bipolar Disorder Patients Helen Link Egger, M.D. Duke University Medical Center Four Year Functional MRI Follow-up of Preschoolers with and without Anxiety Disorders Naomi Eisenberger, Ph.D. University of California, Los Angeles An fMRI Study of Cytokine-Associated Depression and Social Pain James C. Eliassen, Ph.D. University of Cincinnati Identifying a Neurochemical Basis for fMRI Abnormalities in Bipolar Disorder with Phosphorus MRSI Oleg V. Evgrafov, Ph.D., D.Sc. University of Southern California Identification of Genes Involved in Etiology of Schizophrenia by Expression Profiling Andrea Faedo, Ph.D. University of California, San Francisco Role of Tbr1 in Glutamergic Neuron Differentiation: Implications for Schizophrenia Peter A. Fahnestock, M.D. Washington University Effects of Antipsychotic Medications on Energy Intake and Expenditure Christopher P. Fall, Ph.D. University of Illinois, Chicago Neuromodulation of Network Activity in Prefrontal Cortical Microcircuits Jin Fan, Ph.D. Mount Sinai School of Medicine Selective Impairment of Attentional Networks and Treatment Effects of Attentional Functions in Schizophrenia Vincent P. Ferrera, Ph.D. Columbia University Risk and Reward in Dorsolateral Prefrontal Cortex Marc Flajolet, Ph.D. Rockefeller University Identification of Adenosine A2A Receptor Regulatory Proteins to Interfere with Dopamine D2 Signaling Pathway Rachel Helena Flomen, Ph.D. Institute of Psychiatry/King's College London University of London Identification of Functional Variant(s) in the CHRNA7 Region of 15q13-q14 that Predispose to P50 Sensory Gating Deficit and to Smoking Risk in Psychosis Stan B. Floresco, Ph.D. University of British Columbia Neural Encoding in the Prefrontal Cortex During Set Shifting: Alteration by NMDA Antagonists Erika E. Forbes, Ph.D. Western Psychiatric Institute and Clinic University of Pittsburgh A Neuroimaging Study of Positive Affect in Current and Remitted Adolescent Depression Cynthia H.Y. Fu, M.D., MSc, FRCPC Institute of Psychiatry/King's College London University of London The Serotonin Transporter Polymorphism, Cerebral Endophenotypes and Depression Catherine A. Fullerton, M.D., M.P.H. Massachusetts General Hospital Harvard University Utilizing Mecamylamine to Examine the Cognitive Effects of Nicotinic Acetylcholine Receptors in Smokers and Non-smokers with Schizophrenia Amelia Gallitano-Mendel, M.D., Ph.D. University of Arizona The Effect of Antipsychotic Treatment on a Genetic Mouse Model of Schizophrenia Keming Gao, M.D., Ph.D. Case Western Reserve University A Pragmatic Clinical Effectiveness Trial in Multi-morbid Anxious Patients with Bipolar I or II Belinda Garner, Ph.D. Orygen Research Centre University of Melbourne Glucocorticoid Receptor Function in First-Episode Psychosis and in Individuals at Ultra High Risk for Psychosis Anthony J. Giuliano, Ph.D. Beth Israel Deaconess Medical Center Harvard University Stress Reactivity in Individuals at Genetic and Clinical High Risk Schizophrenia Stephen J. Glatt, Ph.D. University of California, San Diego Re-Establishing DRD2 as a Risk Gene for Schizophrenia: Haplotype Mapping and Family-Based Association Analysis Joseph A. Gogos, M.D., Ph.D. Columbia University Hippocampal Structure & Function in a BDNF Val66Met Knock-in Mouse Strain Stephen J. Gold, Ph.D. University of Texas Southwestern Medical Center at Dallas Regulator of G-Protein Signaling 10 (RGS10): A Novel Modulator of Muscarinic Receptor Signaling Doron Gothelf, M.D. Stanford University Are Variants of the COMT Gene a Risk Factor for Longitundinal Decline in Prefrontal Volumes, Reduced Cognitive Performance, and Development of Psychosis in Adolescents with 22q11.2 Deletion Syndrome? Melissa Green, Ph.D. Macquarie University Remediation of Facial Emotion Perception in Psychotic Disorders Cornelius Gross, Ph.D. European Molecular Biology Laboratory Identifying Susceptibility Genes for Mood Disorders Using SNP Analysis in the Mouse Eugenia V. Gurevich, Ph.D. Vanderbilt University The Role of Arrestins in Neurodevelopment: Implications for Schizophrenia Kent C. Harris, Ph.D. Huntington Medical Research Institute Direct Detection of Glial Glutamate Function in Schizophrenia with 13C Acetate MR Spectroscopy Allison G. Harvey, D.Phil. University of California, Berkeley Sleep Disturbances, Emotion Regulation and Bipolar Disorder Takanori Hashimoto, M.D., Ph.D. Western Psychiatric Institute and Clinic University of Pittsburgh Alterations in Cortical Inhibitory Circuitry in Schizophrenia, Regional Specificity and Compensatory Mechanism Kanehiro Hayashi, Ph.D. University of Texas Southwestern Medical Center at Dallas Regulatory Mechanisms of Cytoskeletal Dynamics in Schizophrenia Elizabeth P. Hayden, Ph.D. University of Western Ontario Genetic and Environmental Influences on Temperament in Preschoolers Shawn Hayley, Ph.D. Carleton University Depressive-like Illness Provoked by Stressor and Interferon-alpha: Endogenous Cytokine Mechanisms Peter B. Hedlund, M.D., Ph.D. The Scripps Research Institute The 5-HT7 Receptor - The Missing Link in Depression? Aude Henin, Ph.D. Massachusetts General Hospital Harvard University Magnetic Resonance Spectroscopy in Children At Risk for Bipolar Disorder Loren Keith Henry, Ph.D. Vanderbilt University Medical Center Vanderbilt University Structure-base Modeling of the Serotonin Transporter to Elucidate Sites of Antidepressant Action and Psychiatric Disease-Associated Mutations Carrie L. Heusner, Ph.D. University of California, Los Angeles Identification of Synaptic Molecules that Signal to the Nucleus during Neuronal Plasticity Daphne J. Holt, M.D., Ph.D. Massachusetts General Hospital Harvard University Spatiotemporal Imaging of Emotional Salience in First-Episode Schizophrenia Jinger G. Hoop, M.D. University of Chicago Genetic Testing for Schizophrenia: Views of Patients, Families, and Clinicians Jun Hoshino, Ph.D. University of California, San Francisco Mouse Dapper1's Role in Midbrain Development Yue-Qiao Huang, Ph.D. Drexel University Molecular Mechanism of NMDA Receptor Endocytosis Dan V. Iosifescu, M.D. Massachusetts General Hospital Harvard University Brain GABA Levels and Treatment Response in Major Depressive Disorder Hank P. Jedema, Ph.D. University of Pittsburgh The Influence of the Bed Nucleus of the Stria Terminalis on Monoaminergic Ventral Tegmental Area and Locus Coeruleus Neurons Following Chronic Stress Exposure Jutta Joormann, Ph.D. Stanford University Stress Reactivity and Emotion Regulation in Children at Risk for Depression Mario Francisco Juruena, M.D. Institute of Psychiatry/King's College London University of London Mineralocorticoid Receptor Function in Treatment-Resistant Depressed Patients: Response to Prednisolone Suppression Test Pascal S. Kaeser, M.D. University of Texas Southwestern Medical Center at Dallas Creating Mouse Models for Understanding Molecular Mechansims of Schizophrenia Theodore S. Kalbfleisch, Ph.D. University of Louisville Development of Bioinformatics Infrastructure in Support of Biomarker Discovery in Schizophrenia Studies Jessica H. Kalmar, Ph.D. Yale University Developing Neurobehavioral Endophenotypes to Dissociate Pediatric Bipolar Disorder from Attention-Deficit/Hyperactivity Disorder Kameel N. Karkar, M.D. University of California, San Francisco Cellular and Molecular Characterization of Tangential Migration Mutants Tim Karl, Ph.D. Garvan Institute of Medical Research Conditional NPY Y1 Receptor Deficient Mice - A Potential New Animal Model for Schizophrenia? Tod E. Kippin, Ph.D. University of California, Santa Barbara Antipsychotic Drug Regulation of Neural Stem Cells and Neurogenesis in the Adult Mammalian Brain: Role of Dopamine D2 Receptors and Relation to Clinical Efficacy Yoav Kohn, M.D. Hadassah Medical School Hebrew University Identification of Genes for Psychiatric Disorders in a Genetic Isolate from Israel Sila Konur, Ph.D. University of California, San Diego Evaluation of a Developmental NMDA Receptor Hypothesis for Schizophrenia Sandra J. Kuhlman, Ph.D. Cold Spring Harbor Laboratory Role of GAD67-mediated GABA Synthesis in the Maturation and Dynamics of GABAergic Synapses and Innervation in Mouse Frontal Cortex Po-Hsiu Kuo, Ph.D. National Cheng Kung University Genetics in the Comorbidity of Major Depression and Alcohol Dependence Matthew M. Kurtz, Ph.D. Institute of Living/Hartford Hospital Yale School of Medicine Cognitive Remediation for Schizophrenia: Effects on Distal Outcome Measures and Relationship to Social-Skills Training Cecile D. Ladouceur, Ph.D. Western Psychiatric Institute and Clinic University of Pittsburgh Neural Circuitry Underlying Emotion Regulation in Adolescents at High Risk of Bipolar Disorder Yulia Landa, Psy.D. Weill Medical College of Cornell University Cognitive Behavioral Therapy for Paranoia in Schizophrenia Maria Danet S. Lapiz, Ph.D. University of Texas Health Science Center at San Antonio Effect of Chronic Cold Stress on Cognitive Flexibility in the Rat Attentional Set Shifting and Reversal with Chronic Antidepressant Treatment Amanda J. Law, Ph.D. University of Oxford Molecular and Functional Characterization of Type IV, Neuregulin I, a Novel Isoform Associated with Genetic Risk for Schizophrenia Royce Lee, M.D. University of Chicago A Pilot Study of the Effect of Intranasal Corticotropin-Releasing Hormone on Emotion Processing in Remitted Depression Boaz Levy, Ph.D. Harvard Medical School Recovery of Cognitive Functioning in Bipolar Patients with a Comorbid Substance Use Disorder 3 Months after Discharge Zhi Li, Ph.D. Johns Hopkins School of Medicine Abnormal Dendritic Trafficking of Val66Met BDNF: Role of the Translin/Trax RNA Binding Complex Gregory A. Light, Ph.D. University of California, San Diego Neurophysiological Biomarkers as Targets for Assessing Functioning in Schizophrenia Julie Linker, Ph.D. Virginia Commonwealth University Genetic and Environmental Risk Factors for Suicidal Behavior in Depressed Youth Daniel Lodge, Ph.D. University of Pittsburgh Afferent Modulation of Dopamine System Responsivity in an Animal Model of Schizophrenia Falk W. Lohoff, M.D. University of Pennsylvania Shared Bipolar/Schizophrenia Susceptibility Genes on Chromosome 8p Victor A. Lopez-Soto, M.D. National Institute of Mental Health (NIMH/NIH) Gene-Environment Interaction Study of the Serotonin Transporter and Tryptophan Hydroxlase-2 in War Survivors with Depression and Suicidal Behavior Rajnish Mago, M.D. Thomas Jefferson University Antidepressant-Induced Excessive Sweating: Measurement and Treatment with Terazosin Francoise S. Maheu, Ph.D. National Institute of Mental Health (NIMH/NIH) Neural Circuits Underlying Rewarding Social Interactions and Depression: Influence of Maltreatment on Brain Development in Adolescents Study Sanjay J. Mathew, M.D. Mount Sinai School of Medicine Continuation Riluzole in the Prevention of Relapse Following Ketamine Anna Matynia, Ph.D. University of California, Los Angeles Investigating the Role of 14-3-3 eta in Schizophrenia Clinton B. McCracken, Ph.D. University of Pittsburgh Effects of Deep Brain Stimulation on Afferent Regulation of Nucleus Accumbens Neuronal Activity Mayank Mehta, Ph.D. Brown University Influence of NMDA Antagonists on Hippocampal Dynamics Jose J. Miguel-Hidalgo, Ph.D. University of Mississippi Medical Center Glutamatergic Markers of Astrocytes in Major Depression with Comorbid Alcoholism Peter Milev, M.D., Ph.D. University of Minnesota Functional Anatomy of Illusory Contour Perception in People with Schizophrenia and its Relationship with In Vivo Measures of GABA and Glutamate: Functional MRI and 7 T Magnetic Resonance Spectroscopy Studies Marc J. Miresco, M.D. McGill University Genetic-Environmental Determinants of the Development of Impulsivity Traits in Children Serge A. Mitelman, M.D. Mount Sinai School of Medicine Five-Year Longitudinal Diffusion-Tensor Imaging Assessment of White Matter in Schizophrenia Ganeshwaran H. Mochida, M.D., M.M.Sc. Beth Israel Deaconess Medical Center Harvard University Genes for Developmental Disorders of the Human Cerebral Cortex Sarita A. Mohanty, M.D., MPH University of Southern California Improving Depression Care for the Medically Indigent in a County Emergency Department Jennifer H. Moon, Ph.D. University of Arizona Mood or Medication: A Biobehavioral Marker of Nervous System Integrity in Infants Exposed to SSRI Medications In Utero Anna M. Muller, Ph.D. VA Greater Los Angeles Healthcare System (VA)--West Los Angeles Healthcare Center University of California, Los Angeles Investigating the Impact of a Skills-based Intervention Program on Insight and Engagement in Follow-up Psychiatric Care Inez Myin-Germeys, Ph.D. Maastricht University Stress Reactivity in Psychosis: Linking Phenomenology, Neurobiology & Genetics Syed Naqvi, M.D. Cedars-Sinai Medical Center University of California, Los Angeles PUFA Augmentation for Treatment of Adolescent Unipolar Major Depression Raad Nashmi, Ph.D. University of Victoria Examining Mechanisms of Nicotine Addiction Using Knock-in Mice with Fluorescently Label a4 Nicotinic Receptors Sara Niego, M.D. North Shore-Long Island Jewish Research Institute Metabolic Risk in Treatment-naive Youth with Schizophrenia and Bipolar Disorder Matthew Nolan, Ph.D. University of Edinburgh A Genetic Approach to Investigating the Contribution of the Cerebellum to the Symptoms of Schizophrenia Sherie Lynn Novotny, M.D. University of Medicine & Dentistry of New Jersey (UMDNJ) Oxcarbazepine vs. Placebo in Childhood Autism Peter Olausson, Ph.D. Yale University Chronic Corticosterone Exposure as a Novel Animal Model of Depression: A Proteomics Analysis Urban Osby, M.D., Ph.D. Karolinska Institute Genetic Risks for Suicide in Schizophrenia Thaddeus W.W. Pace, Ph.D. Emory University School of Medicine Inflammatory Signaling and Glucocorticoid Receptor Function in Patients with Major Depression Silvia Paddock (Buervenich), Ph.D. National Institute of Mental Health (NIMH/NIH) Identification and Characterization of Susceptibility Genes for Bipolar Affective Disorder: Multi-Gene Mining and Studies of GRIK2 Tracie Ann Paine, Ph.D. Harvard Medical School Role of Protein Kinase A and CREB in the Medial Prefrontal Cortex in Attention: Relationship to Schizophrenia Abraham A. Palmer, Ph.D. University of Chicago Genetic Studies of Fear Learning in Mice and Humans Michael V. Pantalon, Ph.D. Connecticut Mental Health Center Yale University Efficacy of Motivational Adherence Enhancement for Bipolar Post-Partum Women Sergio Paradiso, M.D., Ph.D. University of Iowa Social Perception-related Brain Activity in Schizophrenia Patients Treated First with Haloperidol and then with Novel Antipsychotics Sang Ki Park, Ph.D. Harvard Medical School Par-4 in Dopamine Signaling and Mood Disorders Mani N. Pavuluri, M.D., Ph.D. University of Illinois, Chicago fMRI Study of the Cognitive and Affective Circuitry Dysfunction in Pediatric Bipolar Disorder Koraly Perez-Edgar, Ph.D. University of Maryland Assessing the Molecular Genetic Links between Early Temperament and Psychopathology in Adolescence: The Potential Role of Dopamine (DRD4), Serotonin (5HTT), and Corticotropin Releasing Hormone (CRH) Roy H. Perlis, M.D. Massachusetts General Hospital Harvard University Pharmacogenomics of Antidepressant-emergent Adverse Effects in Major Depressive Disorder Benjamin D. Philpot, Ph.D. University of North Carolina-Chapel Hill Synaptic Basis for NMDA Receptor Hypofunction in Schizophrenia Elizabeth M. Powell, Ph.D University of Maryland Rescue of GABAergic Cell Loss: Anatomical and Behavioral Profiles Andrew P. Prescot, Ph.D. McLean Hospital Harvard University TE-Averaged Proton Magnetic Resonance Spectroscopy: Monitoring the Effects of High-Dose Oral Glycine Loading on Brain Glycine Levels in Patients with Schizophrenia Gilbert A. Preston, M.D. University of Utah Alpha Frequency rTMS Improves Memory Encoding in Healthy Persons Patrick Provost, Ph.D. Laval University A Link Between RNA Interference, microRNAs and Alzheimer's Disease Marita Pruessner, Ph.D. Douglas Hospital Research Centre McGill University Cortisol Regulation and its Association with Hippocampal Volume in Individuals at Ultra-High Risk for Psychosis Shaun Matthew Purcell, Ph.D. Massachusetts General Hospital Harvard University A Gene-Based Approach to Epistatic Gene-Gene Interaction in Common Neuropsychiatric Disease David C. Purselle, M.D. Emory University Diagnostic Mediators of Suicidal Behavior in African-Americans Jason J. Radley, Ph.D. Salk Institute for Biological Studies Differential Role of the Medial Prefrontal Cortex in Neuroendocrine and Autonomic Responses to Psychological Stress Wiveka Ramel, Ph.D. Stanford University Vulnerability and Depressive Relapse: An fMRI Study of Mood-Memory Relations Michael A. Rapp, M.D., Ph.D. Mount Sinai School of Medicine Neuroplasticity Genes and Gene Products in Recurrent Major Depression Ann M. Rasmusson, M.D. Boston University Neurobiological Predictors of Response to Cognitive Processing Therapy for PTSD in Women with and without Major Depression Amir Raz, Ph.D. New York State Psychiatric Institute Columbia University Attentional Regulation of Affect and Cognition in Impulse Control Disorders Eleonore Real, Ph.D. The Rockefeller University Molecular Mechanisms Controlling Intracellular AMPA Receptor Trafficking Lise Rioux, Ph.D. Drexel University College of Medicine Neuregulins and Olfactory Bulb Plasticity in Schizophrenia Victoria Blythe Risbrough, Ph.D. University of California, San Diego Developing Behavioral and Neuroimaging Markers of Trait Anxiety Melissa M. Rolls, Ph.D. University of Oregon Identification of Proteins Required for Neuronal Compartmentalization Susan Lee Rossell, Ph.D. Mental Health Research Institute of Victoria University of Melbourne Using Ketamine to Model Thought Disorder Laura M. Rowland, Ph.D. Maryland Psychiatric Research Center University of Maryland Neural Changes Associated with Successful Learning in Schizophrenia Kristine Roy, Ph.D. Children's Hospital, Boston Harvard University The Role of Neuregulin-erbB Receptor Signaling in Oligodendrocyte Development and Behavior Scott J. Russo, Ph.D. University of Texas Southwestern Medical Center at Dallas The Role of Ventral Tegmental Area AKT Signaling Proteins in Depression-Related Behaviors and Neuronal Morphology Nancy A. Sachs, Ph.D. Johns Hopkins School of Medicine Cellular and Molecular Characterization of a Frameshift Mutation in DISC1 Michael J. Saganich, Ph.D. Salk Institute for Biological Studies Consequences of Ubiquitin-Dependent Degradation of Beta-Catenin on Synaptic Transmission: Exploring the Mechanism of Lithium Treatment of Bipolar Disorder Amar Sahay, Ph.D. Columbia University Molecular Mechanisms Underlying the Sensitive Period for Anxiety Paola Salvatore, M.D. McLean Hospital Harvard University Comparison of Dimensional and Categorical Representations of the Psychopathology of Psychotic Disorders Rebecca Seal, Ph.D. University of California, San Francisco The Role of Glutamate Release by Monoamine Neurons Thomas W. Sedlak, M.D., Ph.D. Johns Hopkins School of Medicine The Role of Heme Oxygenase in the Oxidative Stress of Alzheimer's Disease Salomao Segal, M.D. Columbia University Neurochemistry, Neuropsychology, and Behavior of Deep Brain Stimulation in the Cingulate Bundle Daniel Senkowski, Ph.D. Research Foundation for Mental Hygiene, Inc. at the Nathan Kline Institute New York University The Cocktail Party Phenomenon in Schizophrenia Nenad Sestan, M.D., Ph.D. Yale School of Medicine Characterization of a Novel Candidate Gene in Schizophrenia Simone G. Shamay-Tsoory, Ph.D. University of Haifa Characterization of Theory of Mind and Empathy Deficits in Schizophrenia: A Neuropsychological Examination of Affective vs. Cognitive Aspects of Social Cognition Jiajun Shi, Ph.D. University of Chicago Association of Neurogenesis and Neuroplasticity Genes with Bipolar Disorder Peter Siekmeier, M.D. McLean Hospital Harvard University The Use of a Neurocomputational Model to Examine Hippocampal Etiologies of Schizophrenia and Develop More Effective Psychopharmacologic Treatments Alan Simmons, Ph.D. University of California, San Diego Differences in Neural Structure and Functioning of PTSD Patients Involving Affective Processing Naomi M. Simon, M.D. Massachusetts General Hospital Harvard University Bipolar Disorder, Chronic Stress, and Accelerated Aging Monsheel S.K. Sodhi, MRPharmS, MSc, Ph.D. University of Alabama at Birmingham The Impact of Post-Transcriptional and Epigenetic Factors on the Psychopathy of Schizophrenia Chantal Martin Soelch, Ph.D. National Institute of Mental Health (NIMH/NIH) Relationship Between Reward Learning, Dopaminergic Function and Anhedonia in Depression: An Event-Related fMRI Study Roland G.W. Staal, Ph.D. Columbia University Mechanisms of Neuronal Exocytosis Revealed by Patch Capacitance Recordings Carl W. Stevenson, Ph.D. University of Nottingham Effects of Early Adversity on Prefrontal Cortex Function During Aversive Learning Holly A. Swartz, M.D. Western Psychiatric Institute and Clinic University of Pittsburgh Psychotherapy for Bipolar II Depression Sharif A. Taha, Ph.D. Ernest Gallo Clinic & Research Center University of California, San Francisco Neural Encoding of Cue Associations in the Nucleus Accumbens During Latent Inhibition Yilang Tang, M.D. Emory University Biochemical Genetics of Catechol O-Methyltransferase Cenk Tek, M.D. Yale School of Medicine Mental Transformations in Schizophrenia in Relation to Negative Symptoms and Deficit Syndrome Dawn Thompson, Ph.D. Ernest Gallo Clinic & Research Center University of California, San Francisco GASP and the Trafficking of the Dopamine Receptor Family Sebastien Thuault, Ph.D. Columbia University Identifying the Molecular and Cellular Mechanisms of Working Memory using a Dual Transgenic Approach Paula Ulery, M.S., Ph.D. University of Texas Southwestern Medical Center at Dallas Role of N-Terminus Phosphorylation on Syntaxin-1 Activity: Implications for Neurotransmitter Release Stefan Ursu, M.D., Ph.D. University of California, Davis Medical Center The Relationship Between Reward Processing, Orbitofrontal Cortex Dysfunction and Negative Symptoms in Unmedicated Schizophrenia Patients: A Functional MRI Exploration Vladimir Vladimirov, M.D., Ph.D. Virginia Commonwealth University Assessment of the Expression and Activation of Cell Survival Molecules in the P13K/AKT Pathway in Schizophrenia Jacob A.S. Vorstman, M.D. Children's Hospital of Philadelphia University of Pennsylvania Clinical and Genetic Aspects of Psychosis in the 22q11.2 Deletion Syndrome Carole Weaver, Ph.D. University of California, San Diego The Role of the Lithium Target GSK3 in the Regulation of Axonal Transport Amy Wenzel, Ph.D. University of Pennsylvania Cognitive and Behavioral Predictors of Suicide Behavior in Suicide Attempters Anne E. West, M.D., Ph.D. Duke University Medical Center Regulation of Activity-Dependent GABAergic Synapse Development by Brain-Derived Neurotrophic Factor Arthur Westover, M.D. University of Texas Southwestern Medical Center at Dallas Outcomes of Managed Care in the Texas Public Mental Health System Tonya Jo White, M.D. University of Minnesota Study of Prefrontal Structure and Function in Children and Adolescents with Velocardiofacial Syndrome Janet M. Witte, M.D., M.P.H. Massachusetts General Hospital Harvard University A Double-Blind, Placebo-Controlled Study of Acamprosate Added to Escitalopram and Behavioral Treatment in Major Depressive Disorder with Comorbid Alcohol Abuse/Dependence Todd S. Woodward, Ph.D. Riverview Hospital University of British Columbia Dysconnectivity of Hippocampo-Prefrontal Neural Systems in Schizophrenia Houhui Xia, Ph.D. Louisiana State University Health Sciences Center Differential Effects on CREB Inactivation by Class-I HDAC Proteins in Depression Jian Xu, Ph.D. Salk Institute for Biological Studies New Knockout Mice of Kainate Receptors, Genes Associated with Schizophrenia and Depression Qing Xu, Ph.D. Weill Medical College of Cornell University Identifying Early Markers of Cortical Interneuron Subtypes Jamie M. Zeitzer, Ph.D. Stanford University Sleep Regulation, Depression and Hypocretin Hanting Zhang, M.D., Ph.D. West Virginia University Regulation of Adult Neurogenesis by Cyclic AMP-Specific Phospohodiesterase 4 (PDE4) Xiaodong Zhang, Ph.D. Duke - NUS Graduate Medical School, Singapore Functional Analysis of Neuronal-specific Tryptophan Hydroxylase-2 (TPH2) Meng-Yang Zhu, M.D., Ph.D. University of Mississippi Medical Center Phox2 Genes, Neurogenes, and Depression Mark J. Zylka, Ph.D. University of North Carolina-Chapel Hill Contribution of Mrgprd-Expressing Pain Circuits to Psychiatric Disorders » View Young Investigator Award Recipients from
|
Announcements
NARSAD Award Winners
Latest News from NARSAD
|
Grantee List
Mei Huang, Ph.D., Vanderbilt University Medical Center, 2005 & 2007 Young Investigator